Ladenburg Thalmann Financial Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $4.12M | Buy |
15,358
+2,471
| +19% | +$662K | 0.03% | 554 |
|
2019
Q3 | $3M | Buy |
12,887
+859
| +7% | +$200K | 0.02% | 655 |
|
2019
Q2 | $2.82M | Buy |
12,028
+23
| +0.2% | +$5.39K | 0.02% | 667 |
|
2019
Q1 | $2.85M | Buy |
12,005
+721
| +6% | +$171K | 0.02% | 631 |
|
2018
Q4 | $3.4M | Sell |
11,284
-214
| -2% | -$64.6K | 0.03% | 486 |
|
2018
Q3 | $4.06M | Buy |
11,498
+2,536
| +28% | +$896K | 0.03% | 453 |
|
2018
Q2 | $2.45M | Hold |
8,962
| – | – | 0.02% | 615 |
|
2018
Q1 | $2.45M | Sell |
8,962
-1,817
| -17% | -$497K | 0.02% | 615 |
|
2017
Q4 | $3.45M | Buy |
10,779
+1,230
| +13% | +$393K | 0.03% | 476 |
|
2017
Q3 | $2.99M | Buy |
9,549
+544
| +6% | +$170K | 0.03% | 471 |
|
2017
Q2 | $2.44M | Buy |
9,005
+19
| +0.2% | +$5.15K | 0.03% | 508 |
|
2017
Q1 | $2.46M | Buy |
8,986
+1,243
| +16% | +$340K | 0.03% | 489 |
|
2016
Q4 | $2.2M | Buy |
7,743
+2,383
| +44% | +$678K | 0.03% | 472 |
|
2016
Q3 | $1.68M | Sell |
5,360
-2,065
| -28% | -$646K | 0.03% | 559 |
|
2016
Q2 | $1.8M | Buy |
7,425
+635
| +9% | +$154K | 0.03% | 505 |
|
2016
Q1 | $1.77M | Buy |
6,790
+820
| +14% | +$214K | 0.03% | 471 |
|
2015
Q4 | $1.82M | Buy |
5,970
+519
| +10% | +$159K | 0.03% | 454 |
|
2015
Q3 | $1.59M | Buy |
5,451
+558
| +11% | +$163K | 0.03% | 455 |
|
2015
Q2 | $1.98M | Sell |
4,893
-681
| -12% | -$275K | 0.04% | 432 |
|
2015
Q1 | $2.35M | Buy |
5,574
+1,085
| +24% | +$458K | 0.05% | 379 |
|
2014
Q4 | $1.54M | Buy |
4,489
+1,421
| +46% | +$486K | 0.03% | 431 |
|
2014
Q3 | $1.02M | Buy |
3,068
+377
| +14% | +$125K | 0.03% | 502 |
|
2014
Q2 | $849K | Sell |
2,691
-2,919
| -52% | -$921K | 0.02% | 564 |
|
2014
Q1 | $1.84M | Buy |
5,610
+39
| +0.7% | +$12.8K | 0.05% | 286 |
|
2013
Q4 | $1.6M | Sell |
5,571
-295
| -5% | -$84.5K | 0.05% | 307 |
|
2013
Q3 | $1.31M | Buy |
5,866
+83
| +1% | +$18.6K | 0.04% | 328 |
|
2013
Q2 | $1.33M | Buy |
+5,783
| New | +$1.33M | 0.05% | 318 |
|